← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dimethicone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:601 | 601 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:601 | 601 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:601 | 601 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:601 | 601 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:601 | 601 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:601 | 601 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6506 | 72934-6506-2 | Hydroquinone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:601 | 601 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:602 | 602 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | ESTRADIOL 10MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dimethicone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:602 | 602 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-525 | 69374-525-25 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:602 | 602 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:602 | 602 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:602 | 602 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-30 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:602 | 602 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6521 | 72934-6521-2 | Hydroquinone; Hydrocortisone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:602 | 602 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-302 | 73702-302-31 | Ketamine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:602 | 602 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:603 | 603 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6100 | 71266-6100-1 | Semaglutide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dimethicone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1014 | 70657-1014-3 | Glutathione | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6515 | 72934-6515-2 | Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:603 | 603 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-301 | 73702-301-15 | Ketamine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:603 | 603 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:604 | 604 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-657 | 70092-657-76 | Ropivacaine PF 0.2% 250ml NS CADD-B FSFF | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1012 | 71283-1012-5 | Dimethyl Sulfoxide; Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-4 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7023 | 72196-7023-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83343-135 | 83343-135-30 | Glutathione | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6516 | 72934-6516-2 | Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:604 | 604 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:604 | 604 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-887 | 69194-887-01 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:605 | 605 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-207 | 70092-207-37 | Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7090 | 71285-7090-1 | Diphenhydramine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:605 | 605 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:605 | 605 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:605 | 605 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:605 | 605 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1035 | 73013-1035-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:605 | 605 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione; Ascorbic Acid; Zinc Sulfate Heptahydrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1035 | 73013-1035-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:605 | 605 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6514 | 72934-6514-2 | Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-155 | 73177-155-27 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:605 | 605 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:606 | 606 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5145 | 26436-5145-5 | Bimix 30/2 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7089 | 71285-7089-1 | Diphenhydramine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:606 | 606 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fludrocortisone Acetate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:606 | 606 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-860 | 33216-860-00 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:606 | 606 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:606 | 606 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1044 | 73013-1044-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:606 | 606 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6390 | 72934-6390-2 | Hydroquinone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6526 | 72934-6526-2 | Hydroquinone; Tretinoin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-27 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:606 | 606 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:607 | 607 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7018 | 72196-7018-1 | Epinephrine 4mg added to D5W | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:607 | 607 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diphenhydramine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:607 | 607 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:607 | 607 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-823 | 33216-823-00 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:607 | 607 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:607 | 607 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1030 | 73013-1030-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7022 | 72196-7022-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:607 | 607 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin; Lidocaine | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6372 | 72934-6372-2 | Hydroquinone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6522 | 72934-6522-2 | Hydroquinone; Tretinoin; Hydrocortisone | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-28 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:607 | 607 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:608 | 608 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-094 | 70092-094-36 | Fentanyl PF 20 mcg/ml in 100 ml NS IVB | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-5023 | 62295-5023-5 | Diphenhydramine Hydrochloride; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:608 | 608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:608 | 608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-824 | 33216-824-00 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:608 | 608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:608 | 608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6379 | 72934-6379-2 | Hydroquinone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:608 | 608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:608 | 608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:608 | 608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:609 | 609 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-202 | 70092-202-75 | Fent 2mcg/mL-Bup 0.125%PF100mlNS CADDYFS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:609 | 609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dipyridamole | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:609 | 609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Flurbiprofen | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-871 | 33216-871-00 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:609 | 609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1045 | 73013-1045-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5227 | 26436-5227-3 | Glycine | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-112 | 70092-112-49 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6383 | 72934-6383-2 | Hydroquinone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2434 | 72627-2434-2 | Hydroxocobalamin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:609 | 609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:609 | 609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:610 | 610 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:610 | 610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxepin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:610 | 610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Flurbiprofen | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:610 | 610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:610 | 610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:610 | 610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1040 | 73013-1040-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1032 | 73013-1032-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6371 | 72934-6371-2 | Hydroquinone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1541 | 72934-1541-2 | Ibuprofen; Salicylic Acid | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:610 | 610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:610 | 610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:611 | 611 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:611 | 611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxepin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:611 | 611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0335 | 71283-0335-3 | Folic Acid | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-260 | 70004-260-32 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:611 | 611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:611 | 611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6387 | 72934-6387-2 | Hydroquinone; Hydrocortisone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4613 | 72934-4613-9 | Ibuprofen; Terbinafine Hydrochloride; Fluconazole; Itraconazole | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:611 | 611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:612 | 612 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6092 | 71285-6092-1 | Phenylephrine 40mg added to NS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxepin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fomepizole | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9160 | 51754-9160-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-125 | 63037-125-25 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6380 | 72934-6380-2 | Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:612 | 612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:612 | 612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:613 | 613 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-433 | 70092-433-50 | RECK in 50 ml NaCl- 50 ml syr | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:613 | 613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxepin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:613 | 613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3342 | 62295-3342-7 | Furosemide | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:613 | 613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:613 | 613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 |